Recent publication 10/13

W. Couet has recently coauthored an article on colistin in Clinical Infectious Diseases with several international opinion leaders, attesting for the recognition of INSERM U1070 in this field.

Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use

Roger L. Nation1,
Jian Li1,
Otto Cars2,
William Couet3,
Michael N. Dudley4,
Keith S. Kaye5,
Johan W. Mouton6,
David L. Paterson7,
Vincent H. Tam8,
Ursula Theuretzbacher9,
Brian T. Tsuji10, and
John D. Turnidge11

1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia
2Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Sweden
3Faculté de Médecine et de Pharmacie, Université de Poitiers, France
4Rempex Pharmaceuticals, San Diego, California
5Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Michigan
6Radboud University Nijmegen Medical Center, The Netherlands
7The University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s Hospital, Australia
8Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Texas
9Center for Anti-Infective Agents, Vienna, Austria
10School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York
11Department of Pathology, Department of Paediatrics, and School of Molecular and Biomedical Sciences, University of Adelaide, Australia


Menu principal

Haut de page